Article Text

Download PDFPDF
Epidemiological treatment for chlamydia co-infection in men who have sex with men (MSM) with a presumptive diagnosis of urethral gonorrhoea in South Australia
  1. Carole Khaw1,2,
  2. Bin Li1,
  3. Russell Waddell1
  1. 1Clinic 275, STD Services, Infectious Diseases Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia
  2. 2Medicine Learning and Teaching Unit, Medical School, University of Adelaide, South Australia, Australia
  1. Correspondence to Dr Carole Khaw, Clinic 275, STD Services, Infectious Diseases Unit, Royal Adelaide Hospital, Adelaide, S. Australia 5000, Australia; carole.khaw{at}adelaide.edu.au

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Concomitant infection with Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) is a reality.1–3 Ancillary treatment for CT is recommended for patients with treatment indications for NG. At Clinic 275, the only public STD clinic in South Australia, epidemiological treatment for CT co-infection is given to heterosexual men with presumptive gonococcal urethritis based on Gram stain results, but until mid-2011, men who have sex with men (MSM) were not given this epidemiological treatment under …

View Full Text

Footnotes

  • Competing interests None.

  • Ethics approval This study was exempt from ethical review as it involved the use of existing collections of non-identifiable data.

  • Provenance and peer review Not commissioned; externally peer reviewed.